Graduate students and researchers from any country have until June 23 to apply for this event, which is supported by FAPESP and will take place at the University of São Paulo’s Ribeirão Preto Medical School in Brazil (imagem: Wikimedia Commons)
Applications open for School of Advanced Science on the Molecular Basis of Inflammatory Diseases
Graduate students and researchers from any country have until June 23 to apply for this event, which is supported by FAPESP and will take place at the University of São Paulo’s Ribeirão Preto Medical School in Brazil.
Applications open for School of Advanced Science on the Molecular Basis of Inflammatory Diseases
Graduate students and researchers from any country have until June 23 to apply for this event, which is supported by FAPESP and will take place at the University of São Paulo’s Ribeirão Preto Medical School in Brazil.
Graduate students and researchers from any country have until June 23 to apply for this event, which is supported by FAPESP and will take place at the University of São Paulo’s Ribeirão Preto Medical School in Brazil (imagem: Wikimedia Commons)
By Maria Fernanda Ziegler | Agência FAPESP – Applications are open until June 23, 2019, for the São Paulo School of Advanced Science on the Molecular Basis of Inflammatory Diseases, to be held November 4-14 at the University of São Paulo’s Ribeirão Preto Medical School (FMRP-USP) in Brazil. The School is being organized by the Center for Research on Inflammatory Diseases (CRID), a Research, Innovation and Dissemination Center (RIDC) funded by FAPESP.
FAPESP is also supporting the event through its São Paulo Schools of Advanced Science Program (SPSAS). Eighty places are available for graduate students and young researchers, half from Brazil and half from other countries. Participants who live outside Ribeirão Preto will receive funds to pay for travel and accommodation.
The School will discuss cutting-edge research on basic and translational aspects of inflammation and inflammatory diseases, focusing on molecular factors fundamental to the discovery of new targets, medications and therapies.
“Chronic inflammatory diseases affect about 10% of the world population. Besides this significant impact, we also know that inflammation is a response to many diseases for which it is not the classic cause, such as cancer and cardiovascular disorders. In the case of cancer, for example, inflammation plays a well-established role in tumor development and progression,” said José Carlos Farias Alves Filho, a professor at FMRP-USP and a member of the School’s organizing committee.
Confirmed speakers include Dan Littman, a professor at New York University; David Sacks, a senior researcher at the US National Institutes of Health (NIH); Mauro Teixeira, a professor at the Federal University of Minas Gerais (UFMG); Rhian Touyz, a professor at the University of Glasgow (UK); and João B. Viola, a senior researcher at Brazil’s National Cancer Institute (INCA).
Applications and more information: inflammation.school.
Republish
Republish
The Agency FAPESP licenses news via Creative Commons (CC-BY-NC-ND) so that they can be republished free of charge and in a simple way by other digital or printed vehicles. Agência FAPESP must be credited as the source of the content being republished and the name of the reporter (if any) must be attributed. Using the HMTL button below allows compliance with these rules, detailed in Digital Republishing Policy FAPESP.